MARA Act of 2025

Senate Bill

S. 2586

119th Congress

MARA Act of 2025

In Committee

Introduced:Jul 31, 2025

Primary Sponsor

Ben Cardin

D - MD

Cosponsors

2

Quick Stats

Policy Area

Health

Summary

The MARA Act aims to prevent shortages of critical life-saving drugs. It requires drug manufacturers to provide data to the FDA to help determine longer expiration dates, and to notify the FDA of increased demand that could lead to shortages. The bill also establishes a grant program to support advanced manufacturing of essential injectable drugs vulnerable to shortages, and directs the GAO to study how Medicare payment changes could help minimize drug shortages.

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Introduced7/31/2025

StatusRead twice and referred to the Committee on Commerce, Science, and Transportation.

ChamberSenate

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

MARA Act of 2025

The MARA Act aims to prevent shortages of critical life-saving drugs. It requires drug manufacturers to provide data to the FDA to help determine longer expiration dates, and to notify the FDA of increased demand that could lead to shortages. The bill also est

Community Breakdown

Pass

0%

Fail

0%

0 predictions

The MARA Act aims to prevent shortages of critical life-saving drugs. It requires drug manufacturers to provide data to the FDA to help determine longer expiration dates, and to notify the FDA of increased demand that could lead to shortages. The bill also establishes a grant program to support advanced manufacturing of essential injectable drugs vulnerable to shortages, and directs the GAO to study how Medicare payment changes could help minimize drug shortages.

Bill Number: 2586
Introduced: 7/31/2025
Status: Read twice and referred to the Committee on Commerce, Science, and Transportation.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: MARA Act of 2025
Bill Number: 2586
Sponsor: No sponsor
Status: Read twice and referred to the Committee on Commerce, Science, and Transportation.
Introduced: 7/31/2025
Summary: The MARA Act aims to prevent shortages of critical life-saving drugs. It requires drug manufacturers to provide data to the FDA to help determine longer expiration dates, and to notify the FDA of increased demand that could lead to shortages. The bill also establishes a grant program to support adva

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

The MARA Act aims to prevent shortages of critical life-saving drugs. It requires drug manufacturers to provide data to the FDA to help determine longer expiration dates, and to notify the FDA of increased demand that could lead to shortages. The bill also establishes a grant program to support advanced manufacturing of essential injectable drugs vulnerable to shortages, and directs the GAO to study how Medicare payment changes could help minimize drug shortages.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

Drug Shortages Prevention and Quality Improvement ActThis bill establishes several programs and requirements to address potential shortages of critical drugs.For example, the bill requires manufacturers of life-saving drugs to submit data to the Food and Drug Administration (FDA) to help determine the longest possible expiration dates for these drugs. Manufacturers must also notify the FDA of any increased demand for life-saving drugs that could lead to shortages. Manufacturers are subject to civil penalties for violations.The bill also (1) establishes a grant program to support advanced manufacturing of essential sterile injectable drugs that are vulnerable to shortages, and (2) requires the Government Accountability Office to study the extent of recent shortages of drugs for which payment is made to hospitals under Medicare and whether payment changes could minimize shortages.

Key Points

Main provisions of the bill

Requires drug manufacturers to provide data to the FDA to determine longer expiration dates for life-saving drugs
Mandates that manufacturers notify the FDA of increased demand that could lead to drug shortages
Establishes a grant program to support advanced manufacturing of essential injectable drugs vulnerable to shortages
Directs the GAO to study how Medicare payment changes could help minimize drug shortages

How This Impacts Americans

Potential effects on citizens and communities

If passed, this bill would directly impact drug manufacturers, the FDA, and Medicare patients. Manufacturers would face new data reporting requirements and potential penalties, while the FDA and government would gain new tools to monitor and prevent drug shortages. This could lead to more consistent supply and availability of critical medications for patients who rely on them.

Policy Areas

Primary Policy Area

Health

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

2586, 119th Congress (2025). "MARA Act of 2025". Source: Voter's Right Platform. https://votersright.org/bills/118-s-2586

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.